Melanoma Flashcards
A 60-year-old man comes to the office because of a 2-cm pigmented lesion on the right lower back that has enlarged progressively for 3 years. No lymph nodes are palpable. Examination of a specimen obtained on punch biopsy shows a Clark Level IV malignant melanoma with a Breslow thickness of 1.2 mm and ulceration. Which of the following is the most appropriate management?
A) Excision with 2-cm margins
B) Preoperative lymphoscintigraphy, sentinel lymph node biopsy, and excision with 1-cm margins
C) Preoperative lymphoscintigraphy, sentinel lymph node biopsy, and excision with 2-cm margins
D) Excision with 1-cm margins, followed by lymphoscintigraphy and sentinel lymph node biopsy at a later date
E) Excision with 3-cm margins, split-thickness skin grafting, and right axillary lymph node dissection
C) Preoperative lymphoscintigraphy, sentinel lymph node biopsy, and excision with 2-cm margins
A melanoma 1.2 mm in thickness on the lower back would best be excisedwith 2-cm margins and a concurrent sentinel lymph node biopsy. Although a few studies cite the adequacy of a 1-cm margin for tumors less than 2 mm in thickness, a punch biopsy was performed in he scenario described, and the final pathology of the complete lesion could show a thicker lesion. In a location where there is sufficient tissue, a 2-cm margin is more appropriate for a lesion that is over 1 mm in thickness. Most authors cite resection margins of 5 mm for melanoma in situ, 1 cm for melanoma less than 0.8 mm, and 2 cm for melanoma between 0.8 and 4 mm.
Most authors cite resection margins of _____ for melanoma in situ
Most authors cite resection margins of 5 mm for melanoma in situ, 1 cm for melanoma less than 0.8 mm, and 2 cm for melanoma between 0.8 and 4 mm.
Most authors cite resection margins of _____ for melanoma less than 0.8 mm
1 cm for melanoma less than 0.8 mm
Most authors cite resection margins of _____ for melanoma between 0.8 and 4 mm
2 cm for melanoma between 0.8 and 4 mm.
Margins cited for melanoma sizes
Most authors cite resection margins of 5 mm for melanoma in situ, 1 cm for melanoma less than 0.8 mm, and 2 cm for melanoma between 0.8 and 4 mm.
Patients with intermediate thickness lesions of 0.8 mm to 4 mm have a ______% incidence of microscopic regional disease.
Patients with intermediate thickness lesions of 0.8 mm to 4 mm have a 20 to 25% incidence of microscopic regional disease. S
Sentinal lymphadenectomy for melanoma
In patients with melanomas greater than or equal to 1 mm in thickness and no clinical evidence of regional lymph node metastases, lymphoscintigraphy is performed preoperatively to define the lymphatic drainage and demonstrate sentinel lymph node location. Sentinel lymphadenectomy is performed most accurately at the time of wide and deep excision of the primary lesion. Later,sentinel lymph node localization may be impaired if the primary lesion has been excised deeply, as the drainage patterns may have been altered by the previous procedure.
When should preoperative lymphoscintigraphy be performed for melanoma?
It is imperative to obtain preoperative lymphoscintigraphy in areas with a high likelihood of aberrant drainage patterns. In the trunk, unpredictable drainage patterns can occur in 20 to 35% of cases.
A 65-year-old Caucasian man comes to the office because of a dark, pigmented lesion on the thumb that he first noticed 3 months ago. There is no history of trauma to the digit. Physical examination shows a variegated lesion with asymmetrical borders in the germinal matrix of the nail bed of the right thumb. Which of the following is the most appropriate first step in management? A ) Amputation to next joint B ) Radiation therapy C ) Shave biopsy D ) Wide excision E ) Observation
C ) Shave biopsy
This pigmented lesion in the patient described could be a post-traumatic subungual hematoma, benign nevus, or subungual melanoma, or benign melanonychia striata longitudinalis. Evaluation of a suspiciously pigmented lesion in the nail bed should commence with a shave biopsy of the lesion. The lesion has been present for 3 months and has not grown out to the sterile matrix; because the patient says there has been no previous trauma, further observation would be inappropriate.
Wide excision or amputation is not warranted until an attempt at diagnosis has been completed. T
Evaluation of a suspiciously pigmented lesion in the nail bed should commence with:
Evaluation of a suspiciously pigmented lesion in the nail bed should commence with a shave biopsy of the lesion.
Melanonychia striata longitudinalis
Benign streaks in the nail plate (melanonychia striata longitudinalis) are extremely common in African American patients and often occur spontaneously with advancing age.
Core biopsy to evaluate nail bed lesion
Evaluation of a suspiciously pigmented lesion in the nail bed should commence with a shave biopsy of the lesion. A core biopsy of the germinal matrix could produce a nail bed and plate abnormality.
Furthermore, there is no need for a core biopsy to determine the depth of the lesion, as the histology and staging of the nail bed are different from the skin.
How long does it take for the nail plate/matrix to grow to the tip after an injury?
After an injury, the nail plate and corresponding matrix grow to tip by 3 to 4 months.
Nailbed: treatment for melanocytic hyperplasia without atypia
Melanocytic hyperplasia without atypia is considered benign and can be observed.
Nailbed: atypia or melanoma in situ
The presence of atypia or melanoma in situ requires complete excision with clear margins. The wound is closed with a full-or split-thickness nail bed graft.
Acral-lentiginous melanoma represent ___ of all cutaneous melanomas
Acral-lentiginous melanoma is found beneath the nail, on the palm of the hand, or on the sole of the foot. These lesions represent approximately 3% of all cutaneous melanomas.
Prognosis of acral-lentiginous melanoma vs others
The prognosis for subungual melanomas is worse than for other cutaneous melanomas, probably because of delayin diagnosis.
When symptoms occur with acral lentiginous melanoma, _____% have metastases
When symptoms occur, 25 to 30% of patients have metastases.
Treatment of subungual hand melanomas
Treatment of subungual hand melanomas consists of amputation through the joint, just proximal to the lesion. Volar flaps are used for the closure of the defect.
Special consideration when amputating for thumb - subungual hand melanoma
For lesions of the thumb, deepening the first space with local z-plasty is recommended to improve function.
Which of the following additional findings in the patient shown is indicative of the most life-threatening syndrome? A ) Hydrocephalus B ) Large or multiple axial nevi C ) Posterior midline nevi D ) “Satellite” nevi E ) Underdevelopment of a limb
A ) Hydrocephalus
Neurocutaneous melanosis connotes the association of a large axial CMN with the CNS involvement.
At least two thirds of those who present with or develop symptomatic CNS disease succumb to the disease process, either because of inexorable “benign” proliferation of melanocytes in the leptomeninges and brain or as a result of malignant degeneration.
Symptomatic hydrocephalus may necessitate the placement of a ventriculoperitoneal or ventriculojugular shunt. Unfortunately, following malignant transformation in the CNS, such shunts afford the malignant melanocytes ready access to the systemic circulation, leading to a rapid demise
Congenital melanocytic nevi (CMN)
Congenital melanocytic nevi (CMN) are birthmarks that are present at birth or become apparent within the first year of life. They are found in 1% to 2% of the general population. CMN are one of several known risk factors for development of melanoma.
Where do melanomas associated with congenital melanocytic nevus occur?
Interestingly, 50% of the melanomas that develop occur within the nevi, but the other 50% occur within the central nervous system (CNS) or within normal skin.
What % of pediatric melanomas are associated with giant congenital melanocytic nevi
Despite significant increase in risk, giant CMN-associated melanomas still account for less than 3% of all pediatric melanomas